U.S. flag

An official website of the United States government

NM_152263.4(TPM3):c.503G>A (p.Arg168His) AND multiple conditions

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Apr 12, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000537032.14

Allele description [Variation Report for NM_152263.4(TPM3):c.503G>A (p.Arg168His)]

NM_152263.4(TPM3):c.503G>A (p.Arg168His)

Gene:
TPM3:tropomyosin 3 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1q21.3
Genomic location:
Preferred name:
NM_152263.4(TPM3):c.503G>A (p.Arg168His)
HGVS:
  • NC_000001.11:g.154172971C>T
  • NG_008621.1:g.24163G>A
  • NM_001043351.2:c.392G>A
  • NM_001043352.2:c.392G>A
  • NM_001043353.2:c.392G>A
  • NM_001278188.2:c.194G>A
  • NM_001278189.2:c.392G>A
  • NM_001278190.2:c.392G>A
  • NM_001278191.2:c.122G>A
  • NM_001349679.2:c.392G>A
  • NM_001364679.2:c.503G>A
  • NM_001364680.2:c.503G>A
  • NM_001364681.2:c.503G>A
  • NM_001364682.1:c.503G>A
  • NM_001364683.1:c.392G>A
  • NM_152263.4:c.503G>AMANE SELECT
  • NM_153649.4:c.392G>A
  • NP_001036816.1:p.Arg131His
  • NP_001036817.1:p.Arg131His
  • NP_001036818.1:p.Arg131His
  • NP_001265117.1:p.Arg65His
  • NP_001265118.1:p.Arg131His
  • NP_001265119.1:p.Arg131His
  • NP_001265120.1:p.Arg41His
  • NP_001336608.1:p.Arg131His
  • NP_001351608.1:p.Arg168His
  • NP_001351609.1:p.Arg168His
  • NP_001351610.1:p.Arg168His
  • NP_001351611.1:p.Arg168His
  • NP_001351612.1:p.Arg131His
  • NP_689476.2:p.Arg168His
  • NP_705935.1:p.Arg131His
  • LRG_681t1:c.392G>A
  • LRG_681t2:c.503G>A
  • LRG_681t3:c.392G>A
  • LRG_681:g.24163G>A
  • LRG_681p1:p.Arg131His
  • LRG_681p2:p.Arg168His
  • LRG_681p3:p.Arg131His
  • NC_000001.10:g.154145447C>T
  • NM_152263.2:c.503G>A
  • NM_152263.3:c.503G>A
  • NR_103461.2:n.491G>A
  • P06753:p.Arg168His
  • p.(Arg168His)
Protein change:
R131H; ARG168HIS
Links:
UniProtKB: P06753#VAR_070069; OMIM: 191030.0005; dbSNP: rs121964852
NCBI 1000 Genomes Browser:
rs121964852
Molecular consequence:
  • NM_001043351.2:c.392G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001043352.2:c.392G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001043353.2:c.392G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001278188.2:c.194G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001278189.2:c.392G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001278190.2:c.392G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001278191.2:c.122G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001349679.2:c.392G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001364679.2:c.503G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001364680.2:c.503G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001364681.2:c.503G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001364682.1:c.503G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001364683.1:c.392G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_152263.4:c.503G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_153649.4:c.392G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NR_103461.2:n.491G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Congenital myopathy 4B, autosomal recessive
Synonyms:
Nemaline myopathy caused by mutation in the tropomyosin 3 gene; Nemaline myopathy 1, autosomal dominant or recessive
Identifiers:
MONDO: MONDO:0012239; MedGen: C5829889; Orphanet: 171433; Orphanet: 171439; Orphanet: 171881; OMIM: 609284
Name:
Congenital myopathy with fiber type disproportion
Synonyms:
Congenital fiber-type disproportion myopathy; Congenital Fiber-Type Disproportion
Identifiers:
MONDO: MONDO:0009711; MedGen: C0546264; Orphanet: 2020

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000635068Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Apr 12, 2023)
germlineclinical testing

PubMed (11)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Combined cap disease and nemaline myopathy in the same patient caused by an autosomal dominant mutation in the TPM3 gene.

Malfatti E, Schaeffer U, Chapon F, Yang Y, Eymard B, Xu R, Laporte J, Romero NB.

Neuromuscul Disord. 2013 Dec;23(12):992-7. doi: 10.1016/j.nmd.2013.07.003. Epub 2013 Oct 2.

PubMed [citation]
PMID:
24095155

Functional effects of congenital myopathy-related mutations in gamma-tropomyosin gene.

Robaszkiewicz K, Dudek E, Kasprzak AA, Moraczewska J.

Biochim Biophys Acta. 2012 Oct;1822(10):1562-9. doi: 10.1016/j.bbadis.2012.06.009. Epub 2012 Jun 27.

PubMed [citation]
PMID:
22749829
See all PubMed Citations (11)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000635068.6

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (11)

Description

This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 168 of the TPM3 protein (p.Arg168His). This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Arg168 amino acid residue in TPM3. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 24095155, 24692096). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Experimental studies have shown that this missense change affects TPM3 function (PMID: 21357678, 22749829, 22798622, 23886664). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt TPM3 protein function. ClinVar contains an entry for this variant (Variation ID: 12450). This variant is also known as p.Arg167His. This missense change has been observed in individual(s) with autosomal dominant nemaline myopathy, cap myopathy, congenital myopathy, and congenital fiber type disproportion (PMID: 12467750, 17376686, 19553118, 21357678, 24507666, 24692096). In at least one individual the variant was observed to be de novo. It has also been observed to segregate with disease in related individuals.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 13, 2024